Indomethacin and Platelet Aggregation in Chronic Glomerulonephritis: Existence of Non-responders
- 11 May 1974
- Vol. 2 (5914) , 301-303
- https://doi.org/10.1136/bmj.2.5914.301
Abstract
Indomethacin given to adults with glomerulonephritis usually reduces their urinary excretion of protein and fibrinogen/fibrin-related (F.R.) antigen. Nevertheless, non-responders exist. Platelet aggregation is significantly more strongly inhibited by indomethacin in good responders than in nonresponders. This supports the hypothesis that the reduction of urinary excretion of F.R. antigen during indomethacin administration is related, at least in part, to inhibition of intrarenal platelet aggregation and of the subsequent fibrin deposition.Keywords
This publication has 10 references indexed in Scilit:
- 50. PHARMACOLOGICAL MODIFICATION OF URINARY EXCRETION OF FIBRINOGEN-LIKE MATERIAL IN GLOMERULONEPHRITIS+Scandinavian Journal of Haematology, 2009
- Enhanced platelet function in glomerular renal disease.1973
- Urinary excretion of fibrinogen-fibrin-related antigen in glomerulonephritis: effect of indomethacin.1973
- Etude de l'agrégation plaquettaire par le ThrombofaxCellular and Molecular Life Sciences, 1972
- Modification by Drugs of Urinary Fibrin Fibrinogen Degradation Products in GlomerulonephritisBMJ, 1972
- Some effects of indomethacin on platelet function, blood coagulation and fibrinolysis.1971
- Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis.1970
- A comparison of an effect of different anti-inflammatory drugs on human plateletsJournal of Clinical Pathology, 1970
- [Histological course of diffuse proliferative glomerulonephritis treated with indomethacin].1969
- The coagulation process and glomerular diseaseThe American Journal of Medicine, 1965